降脂药物和癌症之间的因果关系:一种药物向的门德尔随机化研究
Wenjing Ding1, Liangliang Chen2, Jianguo Xia2
1The Second Clinical Medical School, Anhui University of Chinese Medicine, Hefei, Anhui, China.
Medicine
|May 3, 2024
概括
降脂药物在癌症治疗中显示出潜在的潜力. 蛋白转化酶素素9 (PCSK9) 抑制剂可能会降低胃癌的风险,而3 - 基-3 - 甲基氨酸-CoA减少酶 (HMGCR) 抑制剂对各种癌症具有混合作用.
科学领域:
- 药物基因组学 药物基因组学
- 在瘤学瘤学.
- 心血管药理学心血管药理学
背景情况:
- 新出现的证据表明,降脂药可能会影响癌症治疗.
- 然而,这些药物与癌症风险之间的因果关系仍然不完全理解.
研究的目的:
- 调查蛋白转化酶素素9 (PCSK9) 抑制剂和3-基-3-甲基氨酸-CoA减少酶 (HMGCR) 抑制剂之间的因果关系,以及各种癌症的风险.
- 使用药物标的门德尔随机化方法.
主要方法:
- 采用药物标门德尔式随机化分析.
- 使用与PCSK9和HMGCR抑制剂相关的单核酸多态 (SNP).
- 应用了五种回归方法,以逆方差加权 (IVW) 方法作为主要分析.
主要成果:
- PCSK9抑制剂与胃癌 (GC) 的风险降低显著相关 [IVW:OR=0.482].
- HMGCR的遗传抑制与乳腺癌 (BC),前列腺癌 (PC) 和皮肤癌 (SC) 的风险增加有显著的相关性 [IVW:ORs从1.266到1.617].
- HMGCR抑制剂显示出对GC和肝细胞癌 (HCC) 的保护作用[IVW:OR分别为0.559和0.241].
结论:
- PCSK9抑制剂显示出对胃癌的显著保护作用.
- 对HMGCR的遗传抑制与乳腺,前列腺和皮肤癌的风险增加有关,但HMGCR抑制剂可能会提供对胃和肝细胞癌的保护.
- 需要进一步的临床试验来证实这些发现.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
652
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
652
Cancer Prevention
6.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.2K
Mutagenicity and Carcinogenicity
1.2K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.2K
Hazard Ratio
115
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
115
Statistical Methods for Analyzing Epidemiological Data
363
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
363
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K


